Summit Technology enforces injunction against Chiron Technolas:
This article was originally published in Clinica
Summit Technology (US) has enforced a German injunction against Chiron Technolas, preventing it from manufacturing the Keracor 116 excimer laser system. Chiron Technolas has appealed and has also filed a nullity action with the German Patent Office. Summit filed a similar suit in the US at the end of August, claiming Visx infringed its excimer laser patent (see Clinica No 669/670, p 19).
You may also be interested in...
Less-invasive technologies to treat benign prostatic hyperplasia are fast becoming viable alternatives to medication and surgery. Here's what one researcher in the area, Steven Raman, had to say about the new options.
Novartis’s first digital innovation hub in Asia is launched in India, where the Swiss company hopes to ally with partners to deliver digital solutions for patients at scale.
Senate Finance Committee’s approach to penalize companies for raising WAC list prices is not a ‘price control,’ but a reasonable approach to change the incentives that distort pricing in the supply chain, US HHS Secretary Alex Azar says.